Japanese company reaches $2bn deal to develop Alzheimer’s vaccine
Japan’s Takeda Pharmaceuticals has reached a deal worth up to $2.2bn to develop an Alzheimer’s vaccine made by Swiss start-up AC Immune, as drug companies race to invest in potentially lucrative new treatments for the disease.
Japanese company reaches $2bn deal to develop Alzheimer’s vaccine
2T2C: Talent, Technology, Capital, Cognition

Japanese company reaches $2bn deal to develop Alzheimer’s vaccine

Photo: AFP/Nurphoto/Jakub Porzycki 
Eurasia 21/05/2024 12:25

Japan’s Takeda Pharmaceuticals has reached a deal worth up to $2.2bn to develop an Alzheimer’s vaccine made by Swiss start-up AC Immune, as drug companies race to invest in potentially lucrative new treatments for the disease.

The vaccine is one of a wave of new drugs heading for the market, including lecanemab, developed by Japanese company Eisai, which received US regulatory approval last year, Financial Times reported.

In the Takeda deal, AC Immune will receive an upfront payment of $100mn, rising to $2.1bn if milestones are reached, as well as more than 10 per cent in royalties from any worldwide sales.

The Japanese group could advance the product to late-stage, phase 3 trials, AC Immune said, but regulatory approval could take several years.

Early trials had identified no safety concerns, said Andrea Pfeifer, chief executive of the biotech. But AC Immune would not have efficacy data for the drug until it completed a mid-stage trial within the next 12 months.
#Japan
See Also
World leading Chinese companies
World leading Chinese companies

More and more Chinese companies are making it to the top of the world's largest companies, as this year's Fortune Global 500 list shows. Among the leaders are companies investing in our country.
China launches Shenzhou-19 crewed spaceship
China launches Shenzhou-19 crewed spaceship

China launched the Shenzhou-19 crewed spaceship on Wednesday local time, sending three astronauts -- including the country's first female space engineer -- to its orbiting space station for a six-month mission.

We use cookies on our website. If you consent to their use, we use them to measure and analyze the use of the website.
Information and Settings

Accept